Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Vízkeleti Laura

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2007-2021

2021

Szász, I., Koroknai, V., Vízkeleti, L., Balázs, M.: BRAF-inhibitor-kezelést követően kialakult rezisztencia molekuláris háttere BRAFV600E mutáns melanóma-sejtvonalakban.
Magyar Onkol. 65 (2), 149-156, 2021.

DEA Scopus

Journal metrics:

Q4 Medicine (miscellaneous)

Q4 Oncology

2020

Koroknai, V., Szász, I., Hernandez, V. H., Fernandez, J. N., Cuenin, C., Herceg, Z., Vízkeleti, L., Ádány, R., Ecsedi, S., Balázs, M.: DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
Exp. Dermatol. 29 (1), 39-50, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Dermatology

Q2 Molecular Biology

2019

Szász, I., Koroknai, V., Kiss, T., Vízkeleti, L., Ádány, R., Balázs, M.: Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells.
Melanoma Res. 29 (4), 390-400, 2019.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Dermatology

Q2 Oncology

2017

Vízkeleti, L., Kiss, T., Koroknai, V., Ecsedi, S., Papp, O., Szász, I., Ádány, R., Balázs, M.: Altered integrin expression patterns revealed by microarray in human cutaneous melanoma.
Melanoma Res. 27 (3), 180-188, 2017.

DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

2016

Koroknai, V., Ecsedi, S., Vízkeleti, L., Kiss, T., Szász, I., Lukács, A., Papp, O., Ádány, R., Balázs, M.: Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization.
Melanoma Res. 2, 100-107, 2016.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

2015

Balázs, M., Vízkeleti, L., Ecsedi, S., Ádány, R., Rásó, E., Hegedűs, B., Ladányi, A., Tóvári, J., Tímár, J.: Hazai melanomakutatások: reményt keltő eredmények egy korábban reménytelen daganatban.
Magyar Onkol. 59, 275-281, 2015.

DEA

Journal metrics:

Q3 Medicine (miscellaneous)

Q4 Oncology

Kiss, T., Ecsedi, S., Vízkeleti, L., Koroknai, V., Emri, G., Kovács, N., Ádány, R., Balázs, M.: The role of osteopontin expression in melanoma progression.
Tumor Biol. 36 (10), 7841-7847, 2015.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Medicine (miscellaneous)

2014

Ecsedi, S., Hernandez, V. H., Lima, S. C., Vízkeleti, L., Tóth, R., Lázár, V., Koroknai, V., Kiss, T., Emri, G., Herceg, Z., Ádány, R., Balázs, M.: DNA methylation characteristics of primary melanomas with distinct biological behaviour.
PloS One. 9 (5), e96612, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

Mezey, G., Treszl, A., Schally, A. V., Block, N. L., Vízkeleti, L., Juhász, A., Klekner, Á., Nagy, J., Balázs, M., Halmos, G., Bognár, L.: Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
J. Cancer Res. Clin. Oncol. 140 (10), 1641-1649, 2014.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Medicine (miscellaneous)

Q2 Oncology

10.

Szalóki, G., Krasznai, Z. T., Tóth, Á., Vízkeleti, L., Szöllősi, A. G., Trencsényi, G., Lajtos, I., Juhász, I., Krasznai, Z., Márián, T., Balázs, M., Szabó, G., Goda, K.: The strong in vivo anti-tumor effect of the UIC2 monoclonal antibody is the combined result of Pgp inhibition and antibody dependent cell-mediated cytotoxicity.
PloS ONE. 9 (9), 1-9, 2014.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

2013

11.

Rákosy, Z., Ecsedi, S., Tóth, R., Vízkeleti, L., Hernandez, V. H., Lázár, V., Emri, G., Szatmári, I., Herceg, Z., Ádány, R., Balázs, M.: Integrative genomics identifies gene signature associated with melanoma ulceration.
PLoS One. 8 (1), e54958, 2013.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

2012

12.

Lázár, V., Ecsedi, S., Vízkeleti, L., Rákosy, Z., Boross, G., Szappanos, B., Bégány, Á., Emri, G., Ádány, R., Balázs, M.: Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Melanoma Res. 22 (3), 202-214, 2012.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Dermatology

Q2 Oncology

13.

Vízkeleti, L., Ecsedi, S., Rákosy, Z., Bégány, Á., Emri, G., Tóth, R., Orosz, A., Szöllősi, A. G., Méhes, G., Ádány, R., Balázs, M.: Prognostic relevance of the expressions of CAV1 and TES genes on 7q31 in melanoma.
Front Biosci (Elite Ed). E4 (1), 1802-1812, 2012.

doi DEA

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q3 Immunology and Microbiology (miscellaneous)

Q2 Medicine (miscellaneous)

14.

Vízkeleti, L., Ecsedi, S., Rákosy, Z., Orosz, A., Lázár, V., Emri, G., Koroknai, V., Kiss, T., Ádány, R., Balázs, M.: The role of CCND1 alterations during the progression of cutaneous malignant melanoma.
Tumor Biol. 33 (6), 2189-2199, 2012.

doi DEA

Journal metrics:

Q3 Cancer Research

Q1 Medicine (miscellaneous)

2011

15.

Kitoh, Y., Saio, M., Gotoh, N., Umemura, N., Nonaka, K., Bai, J., Vízkeleti, L., Töröcsik, D., Balázs, M., Ádány, R., Takami, T.: Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.
Int. J. Oncol. 38 (5), 1409-1419, 2011.

doi DEA

Journal metrics:

Q2 Cancer Research

Q1 Oncology

16.

Balázs, M., Ecsedi, S., Vízkeleti, L., Bégány, Á.: Genomics of human malignant melanoma.
In: Breakthroughs in Melanoma Research. Ed.: Yohei Tanaka, InTech, Rijeka, 237-263, 2011. ISBN: 9789533072913

DEA

17.

Márián, T., Trencsényi, G., Goda, K., Szalóky, G., Juhász, I., Vízkeleti, L., Szöllősi, A. G., Lajtos, I., Mikecz, P., Krasznai, Z., Szabó, G., Krasznai, Z. T.: The effect of combined treatment blocking p-glycoprotein function measured using MiniPET in xenograft tumor model.
Nucl. Med. Rev. Cent. East. Eur. 14 (Suppl.), 2011.

DEA

2009

18.

Lázár, V., Ecsedi, S., Szöllősi, A. G., Tóth, R., Vízkeleti, L., Rákosy, Z., Bégány, Á., Ádány, R., Balázs, M.: Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma.
Mod. Pathol. 22 (10), 1367-1378, 2009.

doi DEA

Journal metrics:

D1 Pathology and Forensic Medicine

19.

Vízkeleti, L., Ecsedi, S., Rákosy, Z., Emri, G., Bégány, Á., Szöllősi, A. G., Méhes, G., Ádány, R., Balázs, M.: Expression alterations of genes located on the 7q31 region in human malignant melanomas.
Eur. J. Cancer. 35 (4), 218, 2009.

DEA

2008

20.

Rákosy, Z., Vízkeleti, L., Ecsedi, S., Bégány, Á., Emri, G., Ádány, R., Balázs, M.: Characterization of the 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization.
Cancer Genet. Cytogenet. 182 (2), 116-121, 2008.

doi DEA

Journal metrics:

Q3 Cancer Research

Q3 Genetics

Q3 Molecular Biology

21.

Ecsedi, S., Rákosy, Z., Vízkeleti, L., Juhász, A., Sziklai, I., Ádány, R., Balázs, M.: Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
Otolaryngol. Head Neck Surg. 139 (5), 635-640, 2008.

doi DEA

Journal metrics:

Q1 Otorhinolaryngology

Q1 Surgery

2007

22.

Rákosy, Z., Bégány, Á., Barok, M., Krekk, Z., Gallai, M., Szentirmay, Z., Vízkeleti, L., Ecsedi, S., Vokó, Z., Ádány, R., Balázs, M.: EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis.
Int. J. Cancer. 121 (8), 1729-1737, 2007.

doi DEA

Journal metrics:

Q1 Cancer Research

Q1 Oncology